Toxoplasma gondii-specific antibody responses in serum, intestinal secretions, and milk were identified with an enzyme-linked immunosorbent assay following a single oral infection of mice with strain 76K cysts of T. gondii. Immunoglobulin A (IgA) production began during week 2 of infection in serum and milk and during week 3 of infection in intestinal secretions and persisted in all three throughout the experiment (17 weeks). IgG but not IgM antibodies were detected in intestinal secretions later in the infection. Serum and milk IgG and IgM production began at the same time after infection as did the IgA response. In Western blotting (immunoblotting), intestinal IgA antibodies were shown to react with antigens comigrating with the T. gondii proteins p22, p23, p30, and p43, the 28-kilodalton antigen, and the 55-and 60-kilodalton rhoptry proteins, as recognized by specific monoclonal antibodies. Milk IgA antibodies reacted with antigens comigrating with p30 and p43. Most of the antigens recognized by IgA antibodies were also detected by IgG antibodies. IgA antibodies from all three biological samples detected the same major T. gondii antigens; thus, there was apparently no specific antibody production unique to one locality.
Toxoplasmosis, a coccidian infection, is caused by the obligate intracellular parasite Toxoplasma gondii. Although generally benign for healthy people, infection can result in stillbirth, blindness, mental retardation, and occasionally the death of congenitally infected infants (12) . More recently, this disease has been observed in immunocompromised patients, particularly those with acquired immunodeficiency syndrome but also those with neoplastic disease and bone marrow or heart transplant recipients (12) . In veterinary medicine, cattle abortion and neonatal loss due to toxoplasmosis are of great economic importance in many parts of the world (19) . Infection with T. gondii most commonly occurs via the oral route (10, 13) and induces specific secretory immunoglobulin A (IgA) synthesis in the gut (23) . Secretory IgA antibodies are considered to be protective against intestinal coccidiosis through the inhibition of cell penetration by the parasite and of its subsequent intracellular development (6, 7) . Important insights into the mechanisms that confer resistance to oral or congenital infection may be gained by studies of toxoplasma-specific IgA antibodies arising after infection. With this perspective in mind, using an enzymelinked immunosorbent assay (ELISA), we monitored the kinetics of the IgA antibody response in serum, intestinal secretions, and milk from orally infected mice and made a comparison with the IgG and IgM antibody responses. Furthermore, we used Western blotting (immunoblotting) to detect the T. gondii antigens recognized by these antibodies.
MATERIALS AND METHODS
Parasites. Two strains of T. gondii, RH and 76K, were used in this study. Strain 76K is a low-virulence strain isolated by Laugier and Quilici from a guinea pig (18) . When inoculated into a mouse, this strain regularly causes latent * Corresponding author. toxoplasmosis, with the production of a large quantity of cysts. It was used solely for the peroral infection of mice and was passaged every 2 months by intragastric gavage of cysts collected from the brains of infected animals. Otherwise, RH strain tachyzoites were used throughout and were routinely maintained by serial passage in the peritoneal cavities of OF1 mice.
Mice. Six-to 8-week-old OF1 female mice (IFFA Credo) were used throughout. They were raised in an air-conditioned building (21°C and 60% relative humidity) in a room with controlled daily lighting and had free access to sterile food and water. Day 1 of gestation, for those mice which were mated, was taken as the time at which vaginal plugs were first detected.
MAbs. The production of the anti-T. gondii monoclonal antibodies (MAbs) has been described elsewhere (3, 30 Strips were cut and incubated with different samples (serum and milk diluted 1/100 in TNT, intestinal secretions diluted 1/3 in TNT, MAbs diluted 1/200 in TNT) for 1 h. After three washes in 5% nonfat powdered milk-TNT, the strips were incubated for 1 h in alkaline phosphatase-anti-mouse IgA, IgM, or IgG conjugate (Sigma) diluted 1/1,000 in 5% nonfat powdered milk-TNT. Strips were washed three times in TNT and finally in R buffer (100 mM Tris hydrochloride, 100 mM NaCl, 5 mM MgCl2 [pH 9.5]). Stock solutions for the alkaline phosphatase reaction were prepared as follows: 50 mg of 5-bromo-4-chloro-3-indolyl phosphate in dimethylformamide (Promega Biotec) ml-' and 50 mg of Nitro Blue Tetrazolium in 70% dimethylformamide (Promega) ml-'.
The reaction solution (16.5 RI of 5-bromo-4-chloro-3-indolyl phosphate in dimethylformamide, 33 RI of Nitro Blue Tetra- Datum analysis. Data were expressed as the mean value plus or minus the standard deviation. The paired Student's t test was used to determine the significance of differences between data before infection and during the course of infection (IgA, IgG, and IgM titers). Results for which P was O0.05 were defined as statistically significant.
RESULTS
Time course of intestinal, milk, and serum anti-T. gondii antibody production (IgA, IgG, and IgM) after oral infection. Serum IgA to T. gondii antigens was first observed on day 14 (P < 0.01), peaked on day 42 (P < 0.001), and persisted throughout the experiment (day 122) (Fig. 1) . Similarly, serum IgG and IgM were detected from day 14 onwards (P < 0.001). However, the serum anti-T. gondii IgG titer reached a plateau on day 28 (P < 0.001) and did not change significantly throughout the rest of the study, whereas the serum anti-T. gondii IgM titer peaked on day 14 (P < 0.001) and then decreased progressively (Fig. 1) .
In intestinal secretions, IgA was first observed on day 21 (P < 0.05); the response peaked on day 49 (P < 0.005) and persisted, at a low titer, to the end of experiment (day 122) (Fig. 2) . No IgM was detected in intestinal secretions. In contrast, a significant (P < 0.05) increase in the intestinal anti-T. gondii IgG titer was detectable, but only from day 28 of infection onwards (Fig. 2) .
A milk IgA response began between days 10 and 14 of infection (P < 0.05) and persisted throughout the experiment (day 27) (Fig. 3) . A significant increase in the milk IgG and IgM responses was detected at the same time (P < 0.01 and P < 0.05, respectively). However, the increase in the IgG and IgM titers observed between days 7 and 10 postinfection was not significant. The IgM titer peaked on day 14 and thereafter slowly declined, whereas the IgG antibody response remained on a plateau until the end of the study (Fig.  3) . Seven antigens recognized by milk anti-T. gondii antibodies (21-, 24-, 28-, 30-, 38-, 55-, and 60-kDa bands) showed a migration pattern similar to that of major toxoplasma antigens (p22, p23, 28-kDa antigen, p30, p43, and 55-and 60-kDa rhoptry proteins, respectively), as detected by specific MAbs (Fig. 6) .
DISCUSSION
Previous reports have demonstrated intestinal IgA antibodies (1, 7, 16, 17, 26, 28) and milk IgA antibodies (4, 5, 15, 21, 33) following bacterial, viral, or parasitic infection. In some cases, the presence of pathogen-specific IgA antibodies has been associated with protection against infection by the pathogen (2, 5, 14, 17, 26, 28) . McLeod and Mack (23) first demonstrated the production of intestinal IgA antibodies to T. gondii and later suggested that IgA may play a protective role against toxoplasmosis (22) .
Following oral infection of mice with strain 76K toxoplasma cysts, we were able to detect serum, intestinal, and milk IgA antibodies to T. gondii and to specify the kinetics of the response by using an ELISA. The IgA antibody response began earlier in serum and milk (week 2 after infection) than in intestinal secretions (week 3). Nevertheless, at the intestinal level, the IgA antibody response was the first humoral response, whereas in milk and serum, IgA, IgG, and IgM production all commenced at the same time after infection. Initially, the IgA and IgM antibody titers in serum and intestinal secretions rose in parallel, as described by others for serum antibodies (29) , but the IgM antibody titers peaked earlier than the IgA antibody titers. The time course of IgA production apparently began slightly earlier in Western blotting than in the ELISA (day 7 for serum IgA, day 14 McLeod and Mack (23) gave three oral doses of strain Me49 cysts at a greater concentration than that used here. The presence of intestinal, milk, and serum IgA antibody responses to T. gondii was also demonstrated by Western blots. Serum IgA recognizing p30 in acute and congenital toxoplasmosis (9) or recognizing three major 25-, 35-, and 50-kD bands in accidental laboratory toxoplasmosis (27) has been described. We present here the first description of specific toxoplasma antigens recognized by milk and intestinal IgA antibodies. The almost identical migration patterns of major well-known toxoplasma antigens probed with MAbs and the major bands recognized by anti-T. gondii antibodies in the three biological compartments suggest that the identities of the 4.5-, 21-, 24-, 28-, 30-, 38-, 55-, and 60-kDa bands may be the 4.5-kDa antigen, p22, p23, the 28-kDa antigen, p30, p43, and the 55-and 60-kDa antigens, respectively. The antigens p22, p23, p30, and p43 are major surface toxoplasma proteins (3), the 4.5-kDa entity appears to be a polysaccharide antigen (32), the 28-kDa antigen is a dense granule protein (J.-F. Dubremetz, submitted for publication), and the 55-and 60-kDa antigens are rhoptry proteins (30) . Indeed, several rhoptry antigens are found in the 55-to 60-kDa range (30, 31 ; C. Leriche and J.-F. Dubremetz, submitted for publication), but the identity of the bands observed in the present study remains to be defined. Most of the antigens recognized by milk, intestinal, and serum IgA antibodies were also detected by IgG antibodies, in agreement with the previous work of Partanen et al. (27) for serum. IgA antibodies recognized the same major antigens in serum, intestinal secretions, and milk; thus, specific antibody production was not confined to one biological compartment. In addition, the humoral response varied considerably from one mouse to another, since not all mice produced antibodies recognizing the entire antigenic repertoire. The use of syngeneic mice may partly resolve this problem. Milk IgA antibodies mainly reacted with antigens comigrating with p30, p43, and an antigen with an apparent molecular mass of 40 kDa, whereas intestinal IgA antibodies recognized antigens comigrating with p22, p23, the 28-kDa dense granule protein, p30, p43, the 55-and 60-kDa rhoptry proteins, and two antigens with apparent molecular masses of 40 (faint band) and 50 kDa. Early infection was associated with IgA antibodies to p30 (milk, intestinal, and serum samples), p43 (milk and serum samples), and rhoptry antigens (intestinal secretions), in agreement with previous reports showing that p30 and p43 seem to be the first proteins recognized by human sera in acute toxoplasmosis (8) and that the anti-p30 IgA antibodies are useful human serum markers in congenital and acute toxoplasmosis (9) .
These initial studies of the humoral immune responses against T. gondii point to a close relationship between the systemic and mucosal immune systems during toxoplasmosis. It will be of great interest to differentiate the two types of IgA antibodies (serum and secretory) in milk and intestinal secretions following T. gondii infection. Moreover, following identification of the toxoplasma antigens recognized by the local immune system, particularly by IgA antibodies, the next step will be the molecular characterization of such antigens through gene cloning. Characterization of the role of these toxoplasma antigens in local protective immunity is a prerequesite for future oral vaccination studies.
